Your browser doesn't support javascript.
loading
Corrigendum to: VDAC1 as a target in cisplatin anti-tumor activity through promoting mitochondria fusion.
Luo, Lei; Xiong, Yanyan; Jiang, Nan; Zhu, Xueqin; Wang, Yurun; Lv, Yuan; Xie, Ying.
Afiliação
  • Luo L; Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, 410081, PR China; Changsha Municipal Centre for Disease Prevention and Control, Changsha, 410081, PR China.
  • Xiong Y; Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, 410081, PR China.
  • Jiang N; Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, 410081, PR China.
  • Zhu X; Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, 410081, PR China.
  • Wang Y; Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, 410081, PR China.
  • Lv Y; Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, 410081, PR China. Electronic address: 284792906@qq.com.
  • Xie Y; Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, 410081, PR China. Electronic address: xieying@hunnu.edu.cn.
Biochem Biophys Res Commun ; 587: 170, 2022 Jan 08.
Article em En | MEDLINE | ID: mdl-34952656

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2022 Tipo de documento: Article